Roswell Park Cancer Institute
Duke Cancer Institute
J Natl Compr Canc Netw. 2016 Jan;14(1):19-30. doi: 10.6004/jnccn.2016.0004.
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.
NCCN 前列腺癌指南针对前列腺癌初始诊断后的分期和风险评估，以及局限性、区域性和转移性疾病的治疗选择。还包括疾病监测、复发性疾病的治疗以及转移性去势抵抗性前列腺癌的系统治疗建议。本文总结了 NCCN 前列腺癌专家组在 2016 年指南更新时的重要讨论内容，包括风险分层方法的完善和高危及极高危疾病以及进展性去势敏感疾病男性的治疗新选择。
